Skip to main content
. Author manuscript; available in PMC: 2020 Feb 19.
Published in final edited form as: Anal Chem. 2019 Feb 6;91(4):2805–2812. doi: 10.1021/acs.analchem.8b04699

Figure 6.

Figure 6.

HIC separation of (a) model ADC and (b) commercial ADC Brentuximab vedotin. The dashed lines illustrate that the greater hydrophobicity of the mAb itself for Brentuximab vedotin. Tosoh TSKgel Butyl-NPR, 4.6 × 35 mm, 2.5 μm. MPA: 1.5 M ammonium sulfate, 25 mM sodium phosphate pH 7.0; MPB: 25 mM sodium phosphate pH 7.0 with 25% IPA; flow rate: 0.8 mL/min; column temp: 25 °C.